Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
D000311:Adrenal Glands / Q000378:metabolism; D000315:Adrenalectomy; D000818:Animals; D001581:Benzothiadiazines / Q000494:pharmacology*; D002395:Catecholamines / Q000494:pharmacology*; D002740:Chlorothiazide / Q000494:pharmacology; D003981:Diazoxide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004285:Dogs; D004837:Epinephrine / Q000378:metabolism; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010179:Pancreas / Q000098:blood supply; D014044:Tolbutamide / Q000494:pharmacology*; D014680:Veins
D001581:Benzothiadiazines; D002395:Catecholamines; D007328:Insulin; D002740:Chlorothiazide; D014044:Tolbutamide; D003981:Diazoxide; D009638:Norepinephrine; D004837:Epinephrine